A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial.
A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial.
复制标题
DOI:
10.1186/s12882-015-0052-2
复制
发表时间:
2015-04-16
期刊:
影响因子:
2.3
通讯作者:
Drawz PE
中科院分区:
文献类型:
--
作者:
Cooney D;Moon H;Liu Y;Miller RT;Perzynski A;Watts B;Drawz PE
Primary care providers do not routinely follow guidelines for the care of patients with chronic kidney disease (CKD). Multidisciplinary efforts may improve care for patients with chronic disease. Pharmacist based interventions have effectively improved management of hypertension. We performed a pragmatic, randomized, controlled trial to evaluate the effect of a pharmacist based quality improvement program on 1) outcomes for patients with CKD and 2) adherence to CKD guidelines in the primary care setting. Patients with moderate to severe CKD receiving primary care services at one of thirteen community-based Veterans Affairs outpatient clinics were randomized to a multifactorial intervention that included a phone-based pharmacist intervention, pharmacist-physician collaboration, patient education, and a CKD registry (n = 1070) or usual care (n = 1129). The primary process outcome was measurement of parathyroid hormone (PTH) during the one year study period. The primary clinical outcome was blood pressure (BP) control in subjects with poorly controlled hypertension at baseline. Among those with poorly controlled baseline BP, there was no difference in the last recorded BP or the percent at goal BP during the study period (42.0% vs. 41.2% in the control arm). Subjects in the intervention arm were more likely to have a PTH measured during the study period (46.9% vs. 16.1% in the control arm, P <0.001) and were on more classes of antihypertensive medications at the end of the study (P = 0.02). A one-time pharmacist based intervention proved feasible in patients with CKD. While the intervention did not improve BP control, it did improve guideline adherence and increased the number of antihypertensive medications prescribed to subjects with poorly controlled BP. These findings can inform the design of quality improvement programs and future studies which are needed to improve care of patients with CKD. ClinicalTrials.gov: NCT01290614. The online version of this article (doi:10.1186/s12882-015-0052-2) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
--
作者:
Coresh, J;Wei, L;Klag, MJ
通讯作者:
Klag, MJ
影响因子:
39.2
作者:
Houston, Thomas K.;Allison, Jeroan J.;Hullett, Sandral
通讯作者:
Hullett, Sandral
影响因子:
13.6
作者:
Astor, BC;Eustace, JA;Coresh, J
通讯作者:
Coresh, J
影响因子:
4.8
作者:
Isbel, NM;Haluska, B;Marwick, TH
通讯作者:
Marwick, TH
DOI:
10.1053/j.ajkd.2009.09.014
发表时间:
2010-03
期刊:
American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子:
--
作者:
Muntner P;Anderson A;Charleston J;Chen Z;Ford V;Makos G;O'Connor A;Perumal K;Rahman M;Steigerwalt S;Teal V;Townsend R;Weir M;Wright JT Jr;Chronic Renal Insufficiency Cohort (CRIC) Study Investigators
通讯作者:
Chronic Renal Insufficiency Cohort (CRIC) Study Investigators